EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikazano 201 - 250 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC
Fasciola hepatica	-	-		P Parasites	Details
Fasciolopsis buski	-	-		P Parasites	Details
Flavobacterium meningosepticum	-	-		B Bacteria and similar species	Details
Flexal virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate	-	4301-50-2	Acute Tox. 1; Acute Tox. 2		Details
Fluoribacter bozemanae	-	-		B Bacteria and similar species	Details
fluoroacetates, soluble	-	-	Acute Tox. 2		Details
fluorosilicates, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 4		Details
Fonsecaea compacta	-	-		F Fungi	Details
Fonsecaea pedrosoi	-	-		F Fungi	Details
Francisella tularensis (Type A)	-	-		B Bacteria and similar species	Details
Francisella tularensis (Type B)	-	-		B Bacteria and similar species	Details
Fusobacterium necrophorum	-	-		B Bacteria and similar species	Details
Gardnerella vaginalis	-	-		B Bacteria and similar species	Details
Germiston	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Gerstmann-Straussler-Scheinker syndrome	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Giardia lamblia	-	-		P Parasites	Details
glass microfibres of representative composition [Calcium-aluminium-silicate fibres with random orientation with the following composition (% given by weight): SiO2 55,0-60,0 %, Al2O3 4,0-7,0 %, B2O3 8,0-11,0 %, ZrO2 0,0-4,0 %, Na2O 9,5-13,5 %, K2O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe2O3 < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).]	-	-	Carc. 2		Details
Guanarito virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Haemophilus ducreyi	-	-		B Bacteria and similar species	Details
Haemophilus influenzae	-	-		B Bacteria and similar species	Details
Haemophilus spp.	-	-		B Bacteria and similar species	Details
Hantaan	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hanzalova	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hazara virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
heazlewoodite	-	12035-71-1	Carc. 1A; Muta. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1		Details
Helicobacter pylori	-	-		B Bacteria and similar species	Details
Hepatitis A virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis B virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis C virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis D virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis E virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis G virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Hepatitis viruses not yet identified	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Herpes simplex virus types 1 and 2	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Herpesvirus simiae	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Herpesvirus varicella-zoster	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
hexachloroplatinates with the exception of those specified elsewhere in this Annex show/hide Dipotassium hexachloroplatinate EC / List no: 240-979-3 \| CAS no: 16921-30-5 Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane EC / List no: 258-092-5 \| CAS no: 52672-74-9 Hexachloroplatinic acid EC / List no: 241-010-7 \| CAS no: 16941-12-1 Chloroplatinic acid hexahydrate EC / List no: 629-612-1 \| CAS no: 18497-13-7 Bis(benzyltrimethylammonium) hexachloroplatinate(2-) EC / List no: 255-585-7 \| CAS no: 41909-89-1 Sodium hexachloroplatinate(IV) hexahydrate EC / List no: 626-326-9 \| CAS no: 19583-77-8 Dicesium hexachloroplatinate EC / List no: 240-945-8 \| CAS no: 16902-25-3 Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane EC / List no: 271-555-6 \| CAS no: 68585-32-0 Hexachloroplatinate(2-) EC / List no: - \| CAS no: 16871-54-8 Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with tributylphosphine hydrochloride and N-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine EC / List no: - \| CAS no: 67924-25-8 Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium EC / List no: - \| CAS no: 68516-04-1 Diammonium hexachloroplatinate EC / List no: 240-973-0 \| CAS no: 16919-58-7 Disodium hexachloroplatinate EC / List no: 240-983-5 \| CAS no: 16923-58-3	-	-	Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1		Details
hexane (containing < 5% n-hexane (203-777-6))	-	-	Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3		Details
Histoplasma capsulatum duboisii	-	-		F Fungi	Details
Histoplasma capsulatum var. capsulatum	-	-		F Fungi	Details
Human B-lymphotropic virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human herpes virus 7	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human herpes virus 8	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human immunodeficiency viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human papillomaviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human parvovirus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human rotaviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Human T-cell lymphotropic viruses, types 1 and 2	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
hydrazine-trinitromethane	-	14913-74-7	Expl. 1.1; Self-react. A; Carc. 1B; Acute Tox. 3; Skin Sens. 1		Details

Prikazano 201 - 250 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Footer Nav Items